Fortress Biotech, based in Bay Harbor Islands, Florida, specializes in novel pharmaceuticals with seven marketed products and over 25 developmental programs across oncology, rare diseases, and gene therapy. The company went public in November 2011 and has 186 employees.
FBIO has been in the news recently: Robbins Geller Rudman & Dowd LLP is inviting New Fortress Energy Inc. investors to seek lead plaintiff status in a class action lawsuit concerning financial losses from February 29 to August 8, 2024. The Schall Law Firm is also reminding investors of this lawsuit, which addresses misleading statements made by the company during the same period.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
